Supplement - Moderate-to-severe atopic dermatitis and systemic corticosteroids are associated with insulin resistance and metabolic syndrome

Published: 21 October 2025| Version 1 | DOI: 10.17632/9r6mmx3gvn.1
Contributor:
Emilio Berna-Rico

Description

Supplementary material for a research letter analyzing insulin resistance and metabolic syndrome in patients with moderate to severe atopic dermatitis.

Files

Institutions

  • Hospital Universitario Ramon y Cajal

Categories

Corticosteroid, Atopic Dermatitis, Eczema, Metabolic Syndrome, Insulin Resistance

Licence